Type 1 (n = 60) | Type 2 (n = 10,136) | Positive Predictive Value (%) | |
---|---|---|---|
Demographic Characteristics | |||
Age at diagnosis (years; mean, standard deviation) | 22.7 (12.6) | 55.9 (11.4) | |
< 18 | 16 (26.7) | 20 (0.2) | |
18–39 | 33 (55.0) | 768 (7.6) | |
≥ 40 years | 11 (18.3) | 9348 (92.3) | |
Female | 32 (53.3) | 4456 (43.9) | |
Coding Characteristics* | |||
Number of type 1 codes (median, interquartile range) | 3.0 (4.0) | 0.0 (0.0) | |
Total number of type 1principal codes (median, interquartile range) | 2.0 (2.5) | 0.0 (0.0) | |
Total number of type 1 mixed codes (median, interquartile range) | 1.0 (2.0) | 0.0 (0.0) | |
Number of type 2 codes (median, interquartile range) | 0.0 (1.0) | 1.0 (3.0) | |
Total number of type 2 principal codes (median, interquartile range) | 0.0 (0.0) | 1.0 (2.0) | |
Total number of type 2 mixed codes (median, interquartile range) | 0.0 (0.0) | 1.0 (2.0) | |
Candidate Code Algorithms* | |||
At least 1 type 1 code | 50 (83.3) | 142 (1.4) | 26.0 |
At least 1 type 1 principal code | 42 (70.0) | 65 (0.6) | 39.2 |
At least 1 type 1 mixed code | 38 (63.3) | 108 (1.1) | 26.0 |
At least 1 type 2 code | 43 (71.7) | 92 (0.9) | 31.8 |
At least 1 type 2 principal code | 29 (48.3) | 25 (0.2) | 53.7 |
At least 1 type 2 mixed code | 21 (35.0) | 66 (0.6) | 24.1 |
Ratio of type 1 to type 2 codes ≥ 0.5 (A) | 50 (83.3) | 97 (1.0) | 34.0 |
Ratio of type 1 to type 2 codes ≥ 0.75 | 49 (81.7) | 81 (0.8) | 37.7 |
Ratio of type 1 to type 2 codes ≥ 1 | 49 (81.7) | 78 (0.8) | 38.6 |
Ratio of type 1 to type 2 codes ≥ 2 | 47 (78.3) | 47 (0.5) | 50.0 |
Ratio of type 1 to type 2 codes ≥ 3 | 46 (76.7) | 38 (0.4) | 54.8 |
Ratio of type 1 to type 2 codes ≥ 4 (B) | 43 (71.7) | 32 (0.3) | 57.3 |
Candidate Prescription Algorithms† | |||
At least 1 insulin prescription | 59 (98.3) | 3408 (33.6) | 1.7 |
within 90 days (C) | 58 (96.7) | 615 (6.1) | 8.6 |
within 180 days | 58 (96.7) | 715 (7.1) | 7.5 |
within 365 days | 58 (96.7) | 844 (8.3) | 6.4 |
At least 1 insulin prescription with no other glucose-lowering medication prescription | 36 (60.0) | 80 (0.8) | 31.0 |
within 90 days | 43 (71.7) | 362 (3.6) | 10.6 |
within 180 days | 44 (73.3) | 483 (4.8) | 8.4 |
within 365 days | 45 (75.0) | 653 (6.4) | 6.4 |
At least 1 insulin prescription with no other glucose-lowering medication prescription except metformin | 50 (83.3) | 275 (2.7) | 15.4 |
within 90 days | 53 (88.3) | 451 (4.4) | 10.5 |
within 180 days | 54 (90.0) | 566 (5.6) | 8.7 |
within 365 days | 54 (90.0) | 727 (7.2) | 6.9 |
Multiple daily injections‡ | 47 (78.3) | 273 (2.7) | 14.7 |
within 90 days | 7 (11.7) | 5 (0.0) | 58.3 |
within 180 days | 8 (13.3) | 9 (0.1) | 47.1 |
within 365 days | 12 (20.0) | 13 (0.1) | 48.0 |
Multiple daily injections with no other glucose-lowering medication prescription (D) | 32 (53.3) | 9 (0.1) | 78.0 |
within 90 days | 7 (11.7) | 2 (0.0) | 77.8 |
within 180 days | 8 (13.3) | 6 (0.1) | 571 |
within 365 days | 12 (20.0) | 11 (0.1) | 52.2 |
Multiple daily injections with no other glucose-lowering medication prescription except metformin | 42 (70.0) | 26 (0.3) | 61.8 |
within 90 days | 7 (11.7) | 2 (0.0) | 77.8 |
within 180 days | 8 (13.3) | 6 (0.1) | 57.1 |
within 365 days | 12 (20.0) | 11 (0.1) | 52.2 |
At least 1 metformin prescription | 22 (36.7) | 8979 (88.6) | 0.2 |
Other glucose-lowering medication prescription excluding insulin and metformin | 10 (16.7) | 7673 (75.7) | 0.2 |